M G T Raraty
Affiliation: University of Liverpool
- Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinomaAsma Sultana
Division of Surgery and Oncology, University of Liverpool, Liverpool, UK
BMC Cancer 9:66. 2009..This study aimed to evaluate the safety and tolerability of KAb201, an anti-carcinoembryonic antigen monoclonal antibody, labelled with I(131) in pancreatic cancer (ISRCTN 16857581)...
- Mechanisms of acinar cell injury in acute pancreatitisM G T Raraty
Division of Surgery and Oncology, University of Liverpool, Liverpool L69 3BX, UK
Scand J Surg 94:89-96. 2005..Cytokines and neutrophil activation are also responsible for the systemic inflammatory response typically seen in severe acute pancreatitis...
- [Adjuvant and additive therapy for cancer of the pancreas]J P Neoptolemos
Department of Surgery, Liverpool University, Liverpool, United Kingdom
Chirurg 74:191-201. 2003..Participation in the large, phase-3 study therefore plays a key role in the continued development of the management of pancreas cancer...
- Adjuvant therapy in pancreatic cancer: historical and current perspectivesJ P Neoptolemos
Department of Surgery, University of Liverpool, Liverpool, UK
Ann Oncol 14:675-92. 2003....
- Review article: chemotherapy for pancreatic cancerS Shore
University of Liverpool, Royal Liverpool University Hospital, Liverpool, UK
Aliment Pharmacol Ther 18:1049-69. 2003..Real advances are anticipated over the next five years but are dependent on large randomised controlled trials for success...
- Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancyC M Halloran
Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Liverpool, UK
Br J Surg 95:453-9. 2008..The present prospective study assessed the strategy of using carbohydrate antigen 19.9 (CA19.9) levels to select patients for L-LUS...
- Early and late complications after pancreatic necrosectomyS Connor
Department of Surgery, Royal Liverpool University Hospital
Surgery 137:499-505. 2005..Surgery for pancreatic necrosis is associated with a high morbidity and mortality. The aim of this study was to review the incidence of early and late complications after pancreatic necrosectomy in a large contemporary series of patients...
- Familial pancreatic cancer: a review and latest advancesC J Grocock
Division of Surgery and Oncology, The University of Liverpool, United Kingdom
Adv Med Sci 52:37-49. 2007....